NKG2D-CAR T cells produced remarkable antitumor ability in vivo. Tumor volume and weight were lower in the group treated with NKG2DIL7-CAR T cells than that with NKG2D-CAR T cells. The gene discussed is KLRK1; the disease is neoplasm.